Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1513-1522

  Goralczyk, Regina ^a,d   Barker, Felix M ^c   Buser, Susanne ^b   Liechti, Hans ^a   Bausch, Jochen ^a  

^a Vitamins and Fine Chemicals Division   (Switzerland)

^b Preclinical Research   (Switzerland)

^c PENNSYLVANIA COLLEGE OF OPTOMETRY   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHAXANTHIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CRYSTAL; DOSE RESPONSE; ELECTRORETINOGRAPHY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RETINOPATHY;

ADMINISTRATION, ORAL; ANIMALS; CANTHAXANTHIN; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; FEMALE; LIVER; MACACA FASCICULARIS; MALE; OPHTHALMOSCOPY; RETINA; RETINAL DISEASES;

EID: 0034093998     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arden GB, Barker F. Canthaxanthin and the eye: a critical ocular toxicological assessment. J Toxicol Cut Ocular Toxicol. 1991;10: 115-155.
2. Goralczyk R, Buser S, Bausch J, Bee W, Zühlke U, Barker FM. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin. Invest Ophthalmol Vis Sci. 1997;38:741-752.
3. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retina. Invest Ophthalmol Vis Sci. 1984;25:660-673.
4. Bone RA, Landrum JT. Macular pigment in the Henle's fibre membranes: a model for Haidinger's brushes. Vision Res. 1984;24: 103-108.
5. Bone RA, Landrum JT., Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25:1531-1535.
6. Daicker B, Schiedt K, Adnet JJ, Bermond P. Canthaxanthin retinopathy: an investigation by light and electron microscopy and physicochemical analysis. Graefes Arch Klin Exp Ophthalmol. 1987;235:189-197.
7. Köpcke W, Barker FM, Schalch W. Canthaxanthin deposition in the retina: a biostatistical evaluation of 411 patients. J Toxicol Cut Ocular Toxicol. 1995;14:89-104.
8. Cortin P, Corriveau LA, Rousseau AP, et al. Maculopathie en paillettes d'or. Can J Ophthalmol. 1982;17:103-106.
9. Boudreault G, Cortin P, Corriveau L-A, et al. La rétinopathie à la canthaxanthine: 1. Etude clinique de 51 consommateurs. Can J Ophthalmol. 1983;18:325-328.
10. Cortin P, Boudreault G, Rousseau AP, et al. La rétinopathie à la canthaxanthine: 2. Facteurs prédisposants. Can J Ophthalmol. 1984;19:215-219.
11. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997; 64:211-218.
12. Britton, G, Liaaen-Jensen S, Pfander H, eds. Carotenoids. Vol. 1B: Spectroscopy. Basel: Birkhäuser; 1995:57-61.
13. Handelman GJ, Dratz EA, Reay CC, van Kuijk JGM. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850-855.
14. Snodderly DM, Handelman GJ, Adler AJ. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci. 1991;32:268-279.
15. Snodderly DM, Auran JD, Delori FC. The Macula pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:674-685.
16. Goodwin TW. VII Biosynthesis. In: Isler O, ed. Carotenoids. Basel: Birkhäuser-Verlag; 1971:628-629.
17. Thommen H. VII Metabolism. In: Isler O, ed. Carotenoids. Basel: Birkhäuser-Verlag; 1971:641-656.
18. Metusalach, Synowiecki J, Brown J, Shahidi F. Deposition and metabolism of dietary canthaxanthin in different organs of the arctic charr (Salvelinus alpinus) Can Aquaculture 1996;142:99-106.
19. Schiedt K. Absorption and metabolism of carotenoids in birds, fish and crustaceans. In: Britton G, Liaaen-Jensen S, Pfander H, eds. Carotenoids. Vol. 3. Biosynthesis and Metabolism. Basel: Birkhäuser-Verlag; 1998:307-309.
20. Tyczkowski JK, Hamilton PB. Canthaxanthin as a model for the study of utilization of oxycarotenoids by chicken. Poultry Sci. 1986;7:1350-1356.
21. Seddon JM, Umed AA, Sperduto RD, Hiller R, et al. Dietary carotenoids, vitamins A, C, E, and advanced age related macular degeneration. JAMA. 1994;272:1413-1420.
22. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62:1448S-1461S.
23. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. In: Sies H, ed. Antioxidants in Disease. Mechanisms and Therapies. Advances in Pharmacology. Vol. 38 San Diego: Academic Press; 1996:536-556.
24. Hammond BR Jr, Wooten, BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:397-496.
25. Schalch W, Dayhaw-Barker P, Barker FM. The carotenoids in the human eye. In: Taylor AJ, ed. Nutritional and Environmental Influences on Vision. Boca Raton, FL: CRC Press; 1999:215-150.